Cargando…

Inhibition of MAVS Aggregation-Mediated Type-I Interferon Signaling by Foot-and-Mouth Disease Virus VP3

As a structural protein of the Foot-and-mouth disease virus (FMDV), VP3 plays a vital role in virus assembly and inhibiting the interferon (IFN) signal transduction to promote FMDV replication. Previous studies demonstrated that FMDV VP3 blocks the type-I IFN response by inhibiting the mRNA expressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ekanayaka, Pathum, Lee, Byeong-Hoon, Weerawardhana, Asela, Chathuranga, Kiramage, Park, Jong-Hyeon, Lee, Jong-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473216/ https://www.ncbi.nlm.nih.gov/pubmed/34578357 http://dx.doi.org/10.3390/v13091776

Ejemplares similares

Foot-and-Mouth Disease Virus 3C(pro) Cleaves BP180 to Induce Blister Formation
por: Ekanayaka, Pathum, et al.
Publicado: (2022)

Foot-and-mouth disease virus VP1 target the MAVS to inhibit type-I interferon signaling and VP1 E83K mutation results in virus attenuation
por: Ekanayaka, Pathum, et al.
Publicado: (2020)

Foot-and-Mouth Disease Virus 3C Protease Antagonizes Interferon Signaling and C142T Substitution Attenuates the FMD Virus
por: Ekanayaka, Pathum, et al.
Publicado: (2021)

Foot-and-mouth disease virus non-structural protein 2B downregulates the RLR signaling pathway via degradation of RIG-I and MDA5
por: Weerawardhana, Asela, et al.
Publicado: (2022)

Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing
por: Chathuranga, Kiramage, et al.
Publicado: (2021)

African swine fever virus B175L inhibits the type I interferon pathway by targeting STING and 2′3′-cGAMP
por: Ranathunga, Lakmal, et al.
Publicado: (2023)

Inhibitory Effect of Sargassum fusiforme and Its Components on Replication of Respiratory Syncytial Virus In Vitro and In Vivo
por: Chathuranga, Kiramage, et al.
Publicado: (2021)

Development of Monoclonal Antibody to Specifically Recognize VP0 but Not VP4 and VP2 of Foot-and-Mouth Disease Virus
por: Park, Sun Young, et al.
Publicado: (2022)

Fas-associated factor 1 mediates NADPH oxidase-induced reactive oxygen species production and proinflammatory responses in macrophages against Listeria infection
por: Kim, Tae-Hwan, et al.
Publicado: (2019)

African Swine Fever Virus (ASFV): Immunity and Vaccine Development
por: Chathuranga, Kiramage, et al.
Publicado: (2023)

Negative regulation of NEMO signaling by the ubiquitin E3 ligase MARCH2
por: Chathuranga, Kiramage, et al.
Publicado: (2020)

Anti-Respiratory Syncytial Virus Activity of Plantago asiatica and Clerodendrum trichotomum Extracts In Vitro and In Vivo
por: Chathuranga, Kiramage, et al.
Publicado: (2019)

Enhanced immune response with foot and mouth disease virus VP1 and interleukin-1 fusion genes
por: Park, Jong Hyeon, et al.
Publicado: (2006)

Intracellular sensing of viral genomes and viral evasion
por: Lee, Hyun-Cheol, et al.
Publicado: (2019)

Enhanced inhibition of foot-and-mouth disease virus by combinations of porcine interferon-α and antiviral agents
por: Kim, Su-Mi, et al.
Publicado: (2012)

The Potential Adjuvanticity of CAvant(®)SOE for Foot-and-Mouth Disease Vaccine
por: Ahn, Young-Hoon, et al.
Publicado: (2021)

Preventive effects of quercetin against foot-and-mouth disease virus in vitro and in vivo by inducing type I interferon
por: Lee, Gyeongmin, et al.
Publicado: (2023)

Efficacy of a Novel Multiepitope Vaccine Candidate against Foot-and-Mouth Disease Virus Serotype O and A
por: Chathuranga, W. A. Gayan, et al.
Publicado: (2022)

Rotavirus VP3 targets MAVS for degradation to inhibit type III interferon expression in intestinal epithelial cells
por: Ding, Siyuan, et al.
Publicado: (2018)

Grass Carp Reovirus VP35 Degrades MAVS Through the Autophagy Pathway to Inhibit Fish Interferon Production
por: Lu, Long-Feng, et al.
Publicado: (2021)

The mitochondrial ubiquitin ligase MARCH5 resolves MAVS aggregates during antiviral signalling
por: Yoo, Young-Suk, et al.
Publicado: (2015)

Aggregation of MAVS antiviral protein suggests a mechanism for increased type I interferon production in SLE
por: Shao, Wen-Hai, et al.
Publicado: (2014)

The MAVS and MAV-Nots: PINK1 Clears Prion-like MAVS Aggregates to Extinguish Mitochondrial Inflammatory Signaling
por: Rai, Prashant, et al.
Publicado: (2021)

Production of foot-and-mouth disease virus SAT2 VP1 protein
por: Mamabolo, Mpho Victoria, et al.
Publicado: (2020)

Needleless intradermal vaccination for foot-and-mouth disease induced granuloma-free effective protection in pigs
por: Hwang, Ji-Hyeon, et al.
Publicado: (2019)

Requirements for improved vaccines against foot-and-mouth disease epidemics
por: Park, Jong-Hyeon
Publicado: (2013)

The VP3 Protein of Bluetongue Virus Associates with the MAVS Complex and Interferes with the RIG-I-Signaling Pathway
por: Pourcelot, Marie, et al.
Publicado: (2021)

Type I Interferon Induced and Antagonized by Foot-and-Mouth Disease Virus
por: Ma, Xiao-xia, et al.
Publicado: (2018)

Immune responses in pigs and cattle vaccinated with half-volume foot-and-mouth disease vaccine
por: Park, Min-Eun, et al.
Publicado: (2017)

Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses
por: Lee, Seo-Yong, et al.
Publicado: (2017)

Spontaneous aggregation of the anti-viral MAVS protein in systemic lupus erythematosus: a possible cause of excessive type I interferon production
por: Cohen, PL, et al.
Publicado: (2012)

African Swine Fever Virus EP364R and C129R Target Cyclic GMP-AMP To Inhibit the cGAS-STING Signaling Pathway
por: Dodantenna, Niranjan, et al.
Publicado: (2022)

Zyxin stabilizes RIG-I and MAVS interactions and promotes type I interferon response
por: Kouwaki, Takahisa, et al.
Publicado: (2017)

Immunogenicity and Protection against Foot-and-Mouth Disease Virus in Swine Intradermally Vaccinated with a Bivalent Vaccine of Foot-and-Mouth Disease Virus Type O and A
por: Kim, Dong-Wan, et al.
Publicado: (2023)

Reemergence of Foot-and-Mouth Disease, South Korea, 2000–2011
por: Park, Jong-Hyeon, et al.
Publicado: (2014)

Evaluation of Vaccine Strains Developed for Efficient, Broad-Range Protection against Foot-and-Mouth Disease Type O
por: Hwang, Seong Yun, et al.
Publicado: (2023)

Improved immune responses and safety of foot-and-mouth disease vaccine containing immunostimulating components in pigs
por: Choi, Joo-Hyung, et al.
Publicado: (2020)

Serological Conversion through a Second Exposure to Inactivated Foot-and-Mouth Disease Virus Expressing the JC Epitope on the Viral Surface
por: Hwang, Seong Yun, et al.
Publicado: (2023)

Both STING and MAVS Fish Orthologs Contribute to the Induction of Interferon Mediated by RIG-I
por: Biacchesi, Stéphane, et al.
Publicado: (2012)

Antigenic heterogeneity of capsid protein VP1 in foot-and-mouth disease virus (FMDV) serotype Asia 1
por: Alam, SM Sabbir, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_o26j7bflu73b3h55hrlbbrkj4k